Skip to content

Advertisement

SpringerPlus
SpringerPlus Cover Image
  • Research
  • Open Access

Antityphoid and radical scavenging properties of the methanol extracts and compounds from the aerial part of Paullinia pinnata

  • 1, 3,
  • 1,
  • 1,
  • 1,
  • 2 and
  • 1Email author
SpringerPlus20143:302

https://doi.org/10.1186/2193-1801-3-302

©  Lunga et al.; licensee Springer. 2014

  • Received: 8 March 2014
  • Accepted: 6 June 2014
  • Published:

Abstract

Paullinia pinnata Linn (Sapindaceae) is a medicinal plant, locally used in the West Region of Cameroon for the treatment of typhoid fever. This work was designed to evaluate the antityphoid and antioxidant activities of the extracts and compounds of P. pinnata.

The methanol extracts of the leaves and stems were tested for antityphoid and antioxidant activities. Compounds were isolated, and their structures elucidated by analysis of spectroscopic data in conjuction with literature data and tested for the same activities. The leaf extract was also tested in vivo for its antityphoid potential in a Salmonella typhimurium-induced typhoid fever model in Wistar rats.

Seven known compounds: methylinositol (1), β-sitosterol (2), friedelin (3), 3β-(β-D-Glucopyranosyloxy)stigmast-5-ene (4), (3β)-3-O-(2′-Acetamido-2′-deoxy-β-D-glucopyranosyl) oleanolic acid (5), (3β,16α- hydroxy)-3-O-(2′-Acetamido-2′-deoxy-β-D-glucopyranosyl) echinocystic acid (6) and (3β,)-3-O-[β-D-glucopyranosyl-(1″-3′)-2′-acetamido-2′-deoxy-β-D-galactopyranosyl]oleanolic acid (7) were isolated. Compounds 5 and 1 showed the highest antibacterial (MIC = 0.781-1.562 μg/ml) and DPPH radical scavenging (RSa50 = 19.27 ± 4.43 μg/ml) activities respectively. The maximum extract dose (446.00 mg/kg bw) had comparable activity with ciprofloxacin (7.14 mg/kg bw) and oxytetracycline (5 mg/kg bw). The extract induced significant dose-dependent increase of WBCs and lymphocytes.

These results support the ethnomedicinal use of P. pinnata and its isolated Compounds could be useful in the standardization of antityphoid phytomedicine from it.

Keywords

  • Paullinia pinnata
  • Methylinositol
  • Oleanane-type triterpenoids
  • Antityphoid
  • Radical scavenging properties

Background

Salmonella is one of the genera of the Enterobacteriaceae family. Among the Salmonellae of medical importance are Salmonella typhi, Salmonella paratyphi A, Salmonella paratyphi B; which cause typhoid fever, paratyphoid A and B fevers respectively (Ammah et al. 1999; Gatsing et al. 2006). Salmonella typhimurium is the species responsible for typhoid fever in animal experimental models. Worldwide, there is an estimated 16 million episodes of typhoid fever causing 600 000 deaths each year; the overwhelming majority of infections and deaths occurring in developing countries where typhoid fever is endemic (WHO 1996), associated to peritonitis due to the perforation of ulcerated Peyer’s patches within the small intestine (Everest et al. 2001). These intestinal complications are due only to Salmonella enterica serotype Typhi. Conventional antimicrobial drugs are becoming more and more unavailable to the common man in Africa due to increased costs (Gatsing et al. 2007a). In addition, there is a greater resistance to all the three first line antimicrobials (i.e. chloramphenicol, ampicillin and co-trimoxazol) (WHO 1992). Moreover, chloramphenicol which for long had been the drug of choice for the treatment of typhoid fever, has been withdrawn from the market due to its medulary toxicity (medulary aplasia) (Nauciel and Vildé 2005).

This infection produces an acute inflammation that make the lymphoid tissues stand out from the surrounding mucosa. Moreso, the entrance of Salmonella into the body causes the production of superoxide and nitric oxide which react together to form peroxynitrite a strong biological oxidant (Rastaldo et al. 2007). Oxidative stress occurs when organisms encounter elevated levels of reactive oxygen species, such as superoxide anion, hydrogen peroxide, and hydroxyl radical. Reactive oxygen intermediates are produced at low rates during aerobic respiration in most cells, including prokaryotic cells. To cope with oxidative stress, bacteria have evolved protective responses that enable them to counter the damage and survive. Thus, if the bacteria are prevented from producing reactive oxygen compounds, it can contribute to efficiently fight against the microorganism. When bacteria interact with a eukaryotic host, large quantities of reactive oxygen intermediates are produced (Kamlesh et al. 2007) by phagocytes during uptake of microorganisms, and this is a major microbicidal effector mechanism against pathogenic bacteria. Reactive oxygen species can lead to serious health problems including sickle cell diseases, artherosclerosis, Parkinson’s disease, heart failure, myocardial infarction, Alzheimer’s disease, Schizophrenia, and chronic fatigue syndrom (De Diego-Otero et al. 2009). On the other hand, antioxidant compounds such as polyphenols, phenolic acids, flavonoids, and carotenoids (Magadula et al. 2011) are thought to prevent chronic complications in part through their interactions with reactive oxygen species (ROS) and their ability to scavenge free radicals (Seifried et al. 2007). Thus, it may be interesting to find a medicinal plant with dual antimicrobial and antioxidant properties.

Paullinia pinnata Linn (Sapindaceae) is a liana used in the West Region of Cameroon for the treatment of bacterial infections like typhoid fever, syphilis, gonorrhea, diarrhea and symptoms like stomach-ache and waist pain. In east Africa, the leaves are reported to be used in the treatment of gonorrhea, wounds and microbial infections (Annan et al. 2009). Previous phytochemical investigations have shown the presence of triterpene saponins and cardiotonic catechol tannins (Bowden 1962; Kerharo and Adam 1974), flavone glycosides (Ehab et al. 1999), steroids and steroidal glycosides (Dongo et al. 2009), a cerebroside and a ceramide (Dongo et al. 2009), as well as antibacterial fatty acids (Chabra et al. 1991) in P. pinnata collected from different parts of Africa.

This work was aimed at evaluating the effects of methanol extracts and compounds of P. pinnata in vitro for antisalmonellal and radical scavenging activities and in vivo for antityphoid activity in a Salmonella typhimurium-induced typhoid model in rats.

Methods

Plant materials

The air-dried leaves and stems of P. pinnata were obtained from Dschang, West Region of Cameroon, in January 2009. The identification of plant specimens was done at the Cameroon National Herbarium in Yaounde by Mr Tadjouteu Fulbert, where a voucher specimen was deposited under the reference number 10702/SRFCam.

Extraction and isolation

The air-dried leaves (2.04 Kg) and stems (2.02 kg) of P. pinnata were powdered and extracted with MeOH (7 l × 2, 48 h each) at room temperature to give crude extracts (233.8 g and 152.17 g respectively) after concentration under reduced pressure. The leaf extract (230 g) was exhaustively and successively partitioned with hexane and acetone to afford the hexane (45.2 g), acetone (8 g) and methanol residue (156.8 g) fractions while the stem extract was partitioned into petroleum ether, ethyl acetate and water to obtain the PE fraction (8.08 g), EtOAc fraction (9.13 g) and aqueous residue fraction (109.89 g).

One hundred and fifty grams of the methanol residue fraction was applied to neutral silica gel 60 (0.2-0.5 mm) column (60 × 8 cm) and eluted with mixtures of n-hexane/ethyl acetate and ethyl acetate-methanol of increasing polarity (100:0 → 0:100 with constant polarity increase of 5%) to give 60 fractions which were further grouped on the basis of their TLC band pattern similarities into 5 fractions (F1 to F5). Further column purification of F2 (eluted with EtOAc-MeOH 90:10) on silica gel yielded six fractions denoted F2.1 to F2.6. White niddle-like crystals, formed in F2.3 (EtOAc-MeOH, 95:5) and F2.4 (EtOAc-MeOH, 90:10) were collected and purified on a sephadex gel (LH-20), eluted with an isocratic system of CHCl3-MeOH (40:60) to afford methylinositol (28 mg). Fourty grams of the hexane fraction was applied to neutral silica gel 60 (0.2-0.5 mm) column (60 × 8 cm) and eluted with mixtures of petroleum ether-ethyl acetate of increasing polarity (100:0 → 50:50 with constant polarity increase of 5%) to give 40 fractions. These fractions were further grouped on the basis of their TLC band pattern similarities into 5 fractions (F1 to F5). Fraction F1 (Petroleum ether 100%) was mounted on a silica gel column and eluted with a mixture of Hex-AtOAc of increasing polarity (95:5 → 50:50) to yield 30 fractions which were equally grouped on the basis of their TLC band pattern similarities into 5 sub fractions (F1.1 to F1.5). Sub fractions F1.1 (Hex-EtOAc, 90:10) and F1.4 (Hex-EtOAc, 65:35) both yielded white powders which were purified by sephadex gel (LH-20) column chromatography and eluted with CHCl3-MeOH (4:6) to afford β-sitosterol (20 mg). Finally, F2 (Petroleum ether-EtOAc, 95:5) was mounted on a silica gel column and eluted with a mixture of Hex-EtOAc of increasing polarity (95:5 → 70:30) to yield 10 fractions which were grouped on the basis of their TLC band pattern similarities into 3 sub fractions (F2.1 to F2.3). Sub fractions F2.1 (Hex-EtOAc, 95:5) and F2.2 (Hex-EtOAc, 93:7) yielded transparent crystals which were purified by sephadex gel (LH-20) column chromatography and eluted with CHCl3-MeOH (4:6) to afford friedelin (18 mg).

The EtOAc fraction (7.07 g) was subjected to column chromatography on Rp-18 gel (MPLC, MeOH-H2O 50:50 → 100:0) to afford 3β-(β-D-Glucopyranosyloxy)stigmast-5-ene (119 mg), 3-0-(2′-acetamido-2′-deoxy-β-D-glucopyranosyl)olean-12-en-28-oic acid (170 mg) and 8 fractions. Similarly, F4 (3.60 g) was chromatographed on silica gel column and eluted with CHCl3-MeOH (9:1 → 7:3) to give 4 fractions. F4.4 (448 mg) was subjected to sephadex LH-20 gel column chromatography and eluted with CHCl3-MeOH (1:1) to afford 3-0-(2-acetamido-2′deoxy-β-D-glucopyranosyl)-l6α-hydroxyolean-l2-en-28-oic acid (45 mg). The aqueous residue fraction (76.79 g) was mounted on a D101 macroporous resin column and eluted successively with H2O-EtOH (10:0; 7:3; 5:5; 3:7; 0:10) to obtain 5 fractions denoted F1 to F5 respectively. F5 (946 mg) was purified on a silica gel column, eluted with a stepwise gradient mixture of CHCl3-MeOH-H2O (8:2:0.5 → 6:4:0.5) to afford 3-O-[β-D-glucopyranosyl-(1″-3′)-2′-acetamido-2′-deoxy-β-D-glucopyranosyl]olean-12-en-28-oic acid (40 mg).

Identification of isolated compounds

Optical rotations were measured with a JASCO P-1020 digital polarimeter. UV spectra were obtained using a Shimadzu UV-2401 PC spectrophotometer. IR spectra were recorded on a Bruker Tensor-27 infrared spectrophotometer using KBr pellets. 1D and 2D NMR spectra were performed on Bruker AM-400 and DRX-500 spectrometers (Bruker BioSpin GmBH, Rheinstetten, Germany) with TMS as the internal standard. ESIMS spectra were recorded on a Bruker HTC/Esquire spectrometer. HREIMS was recorded on a Waters AutoSpec Premier P776 spectrometer. Column Chromatography (CC) was performed on silica gel (200–300 mesh, Qingdao Marine Chemical Ltd., Qingdao, China), Rp-18 (40–63 μm, Merk). Fractions were monitored by TLC (GF254, Qingdao Marine Chemical Ltd., Qingdao, China), and by heating silica gel plates sprayed with 10% H2SO4 in ethanol. GC analysis was performed on an HP5890 gas chromatograph equipped with a H2 flame ionization detector.

In vitro antisalmonellal assays

Microorganisms

Four Salmonella species were used in this study, one strain from the American Type Culture Collection (Salmonella typhi ATCC6539) and three clinical isolates (Salmonella paratyphi A; Salmonella paratyphi B and Salmonella typhimurium) from “Centre Pasteur” of Yaounde-Cameroon.

Preparation of bacterial inocula

The preparation of bacterial inocula was done using 18 h old bacterial cultures prepared in nutrient agar. A few colonies of bacteria were collected aseptically and introduced into 10 ml of sterile 0.90% saline solution. The concentration of the suspension was then standardized by adjusting the optical density to 0.10 at 600 nm, corresponding to bacterial cell suspension of about 108 colony-forming units/ml (CFU/ml) (Tereshuck et al. 1997). This cell suspension was diluted 100 times to obtain 106 CFU/ml for the assay.

Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)

The broth micro-dilution method was used for susceptibility testing of bacteria species. The crude extract, its fractions and compounds were tested against the four Salmonella species listed above. The tests were carried out in 96-micro well sterile plates as previously described (Newton et al. 2002). For this, the test substances were dissolved in 5% (v/v) Tween 80 solution and serial two-fold dilutions were made with Mueller Hinton broth to yield volumes of 100 μl/well. One hundred microlitres of 106 CFU/ml bacterial suspensions were added to respective wells containing the test samples and mixed thoroughly to give final concentration ranges of 6250–12.20 μg/ml (for extract and fractions) and 100–0.781 μg/ml (for compounds). The dilution solution, 5% Tween 80, did not show inhibitory effects on the growth of the bacteria. The cultured micro plates were covered and incubated at 37°C for 24 h. Inhibitory concentrations of the extracts were detected after addition of 50 μl of 0.20 mg/ml MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Sigma-Aldrich, South Africa) and incubation at 37°C for 30 min (Mativandlela et al. 2006). Viable bacteria change the yellow dye MTT to a blue color. The lowest concentration at which no visible color change was observed was considered as the MIC. The bactericidal concentrations were determined by adding 50 μl aliquots of the preparations (without MTT), which did not show any visible color change after incubation during MIC assays, into 150 μl of extract-free Mueller Hinton broth. These preparations were further incubated at 37°C for 48 h and bacterial growth was revealed by the addition of MTT as above. The lowest concentration at which no visible color change was observed was considered as the MBC. Gentamycin and Ciprofloxacin were used as reference drugs and tests were performed in triplicate.

In vivo therapeutic test

This test was carried out using a Salmonella typhimurium-induced typhoid model in Whistar rat. The Whistar rats (7–8 weeks and 150–170 g) were reared in the Animal house of the Department of Biochemistry, University of Dschang-Cameroon. Only the crude extract was used in the treatment of infected animals. Prior to the test, animals were housed under the test conditions for a period of one week.

Ethical guidelines

The experiments were conducted according to the ethical guidelines of Committee for Control and Supervision of Experiments on Animals (Registration no. 173/CPCSEA, dated 28 January, 2000), Government of India, on the use of animals for scientific research.

Animals were immunosuppressed two day before infection by the oral administration of 30 mg/kg bw. of cyclophosphamide as previously described (Abhishek et al. 2008).

Typhoid induction

A Salmonella typhimurium suspension was prepared at 0.5 Mc Farland turbidity scale as above. This solution (1 ml), containing about 108 CFU was orally administered to each animal (Kamgang et al. 2006). Only infected animals were selected on the basis of their fecal colony counts and used.

Grouping of animals

Animals were arranged into eight groups of four animals each, two males and two females in separate cages according to sex. Except for group 1 animals which were not infected, the rest were infected. The animals were treated as follows:

  •  Group one (reference groups) was not infected and received distilled water during the treatment period.

  •  Group two (negative control group) received only distilled water during the treatment period.

  •  Groups three and four (positive control groups) received ciprofloxacin (7.14 mg/kg bw) and oxytetracycline (5 mg/kg bw) during the treatment respectively.

  •  Group five, six, seven and eight (test groups) received the P. pinnata leaf extract at concentrations of 55.75, 111.50, 223.00 and 446.00 mg/kg bw, corresponding to MIC, 2MIC, 4MIC and 8MIC respectively.

Food and water were given to the animals before and during the treatment ad libitum. Treatment was done by administering the extract orally, every morning at the same time. Each day, the fecal matter was collected during the administration process and assessed for the stool bacterial density. The extent to which the animals complied with treatment was studied by counting the amount of bacterial colonies in the fecal samples using the following protocol.

  •  0.10 g of fecal matter was completely dissolved in 5 ml of autoclaved distilled water.

  •  50 μl of the resulting solution was spread on the surface of solidified 0.9% saline SS agar in the 35 mm type Petri dish.

  •  After incubation for 18 h at 37°C, the number of colonies following growth of Salmonella typhimurium in each Petri dish was counted and recorded.

  •  The results were converted into the number of colonies per gram of fecal matter per animal.

Effect of extract treatment on hematological parameters

Each time a group was completely healed, the animals were sacrificed by chloroform anaesthesia and blood was collected, by cardiac puncture after dissection, into heparinized tubes. Blood parameters including hematocrite, Red Blood Cells (RBCs), White Blood Cells (WBCs), lymphocytes, monocytes, eosinophils, basophils and neutrophils were evaluated using the heparinized blood (Benson and Cales 1992; Theml 2000).

Radical scavenging activity

The radical scavenging activities of crude extract, fractions and compounds were evaluated spectrophotometrically using the stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical (El-Ghorab et al. 2006). When DPPH reacts with an antioxidant compound, which can donate hydrogen, it is reduced. The changes in color were measured at 517 nm under UV/Visible light spectrophotometer (Jenway, model 1605). Pure methanol was used to calibrate the counter and all test samples were prepared in methanol (4 mg/ml for plant extracts, compounds and vitamin C, the reference drugs). Twofold serial dilutions were made to obtain a concentration range from 2000–62.50 μg/ml. The methanol solution of DPPH (20 mg/l) was prepared daily. The absorbance (Ab) of DPPH without the test samples was read. The mixtures were made by adding 100 μl of test sample to 900 μl of DPPH solution. The content was mixed and incubated at room temperature in the dark. The absorbance (As) was recorded after 30 min. Experiments were carried out in triplicates and the percentages of DPPH reduction by test samples were compared to that of vitamin C (reference drug) and were calculated by the following formula:
% RSa = Ab − As / Ab × 100 .

Where,

Ab: absorbance of DPPH solution without test sample,

As: absorbance of DPPH solution mixed with the test sample,

RSa: radical scavenging activity.

The radical scavenging percentages were plotted against the logarithmic values of concentration of test samples and a linear regression curve was established in order to calculate the RSa50, which is the amount of sample necessary to decrease by 50% the total free radical DPPH (Yassa et al. 2008).

Statistical analysis

The data were subjected to one-way analysis of variance, and differences between samples at P ≤ 0.05 were determined by Waller-Duncan test using the Statistical Package for the Social Sciences (SPSS) program. The experimental results were expressed (where appropriate) as mean ± standard deviation of three replicates.

Results and discussion

The following known compounds: methylinositol (1) (Zafer et al. 2007) whose 13C NMR data were very close to those of L-quebrachitol (Kallio et al. 2009; De Almeida et al. 2012), β-sitosterol (2) (Gupta et al. 2011), friedelin (3) (Klass et al. 1992; Mahato and Kundu 1994) (Figure 1) were isolated and identified in the leaves of P. pinnata. From the MeOH stem extract, 3β-(β-D-Glucopyranosyloxy)stigmast-5-ene or daucosterol (4) (Alam et al. 1996), 3-0-(2′-acetamido-2′-deoxy-β-D-glucopyranosyl)olean-12-en-28-oic acid (5) (Ngassapa et al. 1993; Abdel-Kader et al. 2001), 3-0-(2-acetamido-2′deoxy-β-D-glucopyranosyl)-l6α-hydroxyolean-l2-en-28-oic acid (6) (Ngassapa et al. 1993) and 3-O-[β-D-glucopyranosyl-(1″-3′)-2′-acetamido-2′-deoxy-β-D-glucopyranosyl]olean-12-en-28-oic acid (7) (Arafa et al. 2005) were isolated and identified (Figure 1). The compounds isolated in the present study were formerly isolated from other plants and the biological activities of some were demonstrated (Lee et al. 2007; Jiang et al. 2013). P. pinnata extract has been proven to possess vascular relaxation properties (Chabra et al. 1991).
Figure 1
Figure 1

Chemical structures of compounds from the leaves (1-3) and stems (4-7) of P. pinnata.

The crude extracts and isolated compounds showed variable antibacterial activities against the tested salmonellae species (Table 1). Salmonella typhi was less sensitive to all the tested substances. The isolated compounds were less efficient on salmonella than the reference drugs except compound 5 which showed strong antibacterial activity, comparable to ciprofloxacin in some cases. The structures of 5 and 7 are similar, but 5 showed stronger antibacterial activity compared to 7 against the tested species. This suggests that the introduction of a β-D-galactopyranose group at C-3′ of the sugar moiety of C-3 reduced the antisalmonellal activity of 7. In addition, the structure-activity relationship shows that the introduction of an -OH group at C-16 in compound 6 considerably reduced its antibacterial activity. More so, comparing the MIC and MMC values of compound 2 and its analogue 4, it is seen that the presence of the C-3- β-D-glucopyranose group in 4 considerably increased the antibacterial activity of the latter. Thus, the presence or absence of C-16-OH and C-3′- or C-3 β-D-hexopyranose groups play a critical role in reducing or increasing the anti-salmonellal properties of these types of oleanane triterpenoids and steroidal terpenes.
Table 1

Minimum inhibitory (MIC) and bactericidal (MBC) concentrations (μg/ml) of extracts and compounds from P. pinnata

Test substance

Parameter (μg/ml)

S. typhi

S. paratyphi A

S. paratyphi B

S. typhimurium

Extracta

MIC

781

48

781

781

MBC

781

390

3125

3125

MBC/MIC

1

8

4

4

Extractb

MIC

781

781

390

390

MBC

1562

1562

1562

3125

MBC/MIC

2

2

4

8

1

MIC

6.25

1.562

1.562

25

MBC

50

12.5

12.50

100

MBC/MIC

8

8

8

4

2

MIC

100

100

100

100

MBC

/

/

/

/

MBC/MIC

nd

nd

nd

nd

3

MIC

25

50

100

100

MBC

50

100

100

/

MBC/MIC

2

2

1

nd

4

MIC

50

25

12.5

25

MBC

100

100

50

50

MBC/MIC

2

4

4

2

5

MIC

1.562

1.562

0.781

0.781

MBC

1.562

1.562

1.562

0.781

MBC/MIC

1

1

2

1

6

MIC

25

25

12.50

12.5

MBC

25

50

50

25

MBC/MIC

1

2

4

2

7

MIC

25

50

3.125

12.5

MBC

50

100

6.250

12.5

MBC/MIC

2

2

2

1

Ciprofloxacin

MIC

0.195

0.195

1.562

0.781

MBC

0.781

0.781

1.562

3.125

MBC/MIC

4

4

1

4

Gentamycin

MIC

6.25

1.562

3.125

3.13

MBC

12.5

6.25

12.5

6.25

MBC/MIC

2

4

4

2

Extracta: methanol extract of the leaves; Extractb: methanol extract of the stems; nd: not determined (greater than 100 μg/ml).

Compound 2 (B-sitosterol) was formally isolated from Citrus grandis fruits and shown to possess activity against gram-positive (Bacillus cereus, Bacillus subtilis and Staphilococcus aureus) and gram-negative (Escherichia coli and Salmonella enteritidis) bacteria, with MIC value of 300 μg/ml (Matook et al. 2005). Compound 3 (Friedelin), isolated from the stem bark of Vismia rubescens demonstrated antibacterial activities against Salmonella typhi, Staphylococcus aureus, Pseudomonas aeruginosa with MIC values of 25–200 μg/ml. (Tamokou et al. 2009). The MBC/MIC ratios were generally less than or equal to 4 for extract and most of the compounds, indicating the bactericidal nature of the tested samples on the Salmonellae species (Lalitagauri et al. 2004; Gatsing et al. 2007b). These compounds are isolated from P. pinnata for the first time and the antibacterial activities of Compounds 1, 5–7 are being reported herein for the first time.

The crude extract of the leaves was tested in vivo on a Salmonella typhymurium-induced typhoid model in Wistar rats. In infected animals, stools were either soft with mucus, liquid or were moulded and smooth but mucus coated. Sometimes, the presence of blood and mucus made the stool to appear dark and shinny. These animals were weak and less active, with their fur standing at right angles to the body surface instead of the normal sleeping position. The slender body became more bulky, with some of the animals even ‘coughing’. All of these characterized the establishment of infection in the experimental animals, which was clearly revealed by the growth of Salmonella colonies on Petri dishes after the culturing of fecal matter.

Treatment with plant extracts improved the general condition of animals. The bacterial load (colonies/gram of fecal matter) significantly (p < 0.05) dropped with time in a dose-dependent manner compared to the negative control (group 2) during treatment (Figure 2). From this Figure, groups 3 (ciprofloxacin), 4 (oxytetracycline), 5 (55.75), 6 (111.50), 7 (223.00) and 8 (446.00 mg/kg bw of extract) were healed after 4, 4, 8, 6, 5 and 4 days of treatment respectively. No significant difference (p ≥ 0.05) was noted in terms of the number of colonies in fecal matter between the extract at the highest dose (446 mg/kg bw) and the reference antibiotics (ciprofloxacin and oxytetracycline) which collectively stopped bacterial multiplication in four days of treatment. In the other treatment groups, the disease condition was eliminated progressively as a function of the extract dose. In the negative control (the untreated group), the stool bacterial charge remained relatively high compared to those of the treated groups throughout the test period. Analysis of blood parameters after treatment shows that, apart from WBCs and lymphocytes which significantly increased (p < 0.05) in a dose-dependent manner in the extract treated groups, the rest of the hematological parameters did not show any significant treatment related variation (Table 2). Classically, during typhoid fever infection, there is leukopenia, a decrease in the number of circulating white blood cells, with eosinopenia and relative lymphocytosis. There is also a positive reaction for Salmonella typhi or paratyphi on blood cultures (Weinberg et al. 2008). P. pinnata crude extract could therefore fight against typhoid fever by inducing the proliferation of WBCs and lymphocytes in the body as revealed in this study.
Figure 2
Figure 2

Evolution of treatment of infected rats as a function of P. pinnata extract dose. CE: Crude extract.

Table 2

Variation of hematological parameters of rats after treatment with P. pinnata methanol leaf extract

Blood parameter

Dose (mg/Kg bw.)

0

55.75

111.5

223

446

Cipro (7.14)

Oxy (5.00)

Ref

Hematocrite (%)

35.71 ± 4.71a

37.78 ± 3.76a

33.81 ± 6.240a

39.22 ± 2.51a

36.04 ± 1.27a

37.59 ± 2.13a

37.35 ± 2.44a

38.36 ± 1.58a

RBC Count (106 mm−3)

4.023 ± 0.096a

4.016 ± 0.090a

4.126 ± 0.138a

4.030 ± 0.160a

4.053 ± 0.070a

4.210 ± 0.253a

4.193 ± 0.209a

4.333 ± 0.145a

WBC Count (103 mm−3)

5.356 ± 0.741ab

5.320 ± 0.534ab

6.266 ± 0.862bc

7.553 ± 0.642c

6.606 ± 1.572bc

5.833 ± 1.264bc

4.040 ± 0.065a

4.070 ± 0.075a

Lymphocytes (%)

51.000 ± 4.582b

51.000 ± 6.082b

54.666 ± 4.163bc

65.333 ± 7.094c

65.333 ± 5.859c

52.333 ± 3.785b

45.000 ± 6.000b

33.333 ± 4.509a

Monocytes (%)

6.333 ± 0.577ab

6.166 ± 0.577ab

5.666 ± 0.763a

7.667 ± 0.288ab

6.500 ± 1.500ab

8.000 ± 1.322b

5.667 ± 1.154a

6.833 ± 0.763ab

Eosinophils (%)

0.667 ± 0.288a

0.833 ± 0.288a

1.000 ± 0.000a

1.667 ± 0.288b

0.667 ± 0.288a

0.833 ± 0.288a

0.833 ± 0.288a

1.000 ± 0.000a

Basophils (%)

0.833 ± 0.577a

0.833 ± 0.288a

1.000 ± 0.000a

0.833 ± 0.288a

0.833 ± 0.288a

0.667 ± 0.577a

0.833 ± 0.288a

0.167 ± 0.288a

Neutrophils (%)

37.500 ± 8.261a

36.333 ± 1.892a

35.667 ± 1.892a

30.667 ± 1.607a

35.167 ± 9.278a

37.333 ± 5.299a

40.833 ± 5.392a

54.833 ± 1.154b

Across each line, values with different letter superscripts are significantly different, at p < 0.05. (Waller Dunkan test). Ref: values from animals of group 1, that were not infected and received distilled water during treatment; Cipro: ciprofloxacin; Oxy: oxytetracycline.

The crude extracts and compound 1 (RSa50 values of 19.27 ± 4.43) presented radical scavenging activities against stable DPPH free radical in a concentration-dependent manner. The other compounds did not display appreciable radical scavenging potentials (Table 3). However, structure-activity relationship of the compounds shows that the introduction of 3-glucopyranose, C-16-OH or 3′-galactopyranose groups respectively in 4, 6 and 7 greatly increased the radical scavenging activities of these compounds. Microbial infections may lead to an increased formation of highly reactive molecules that can cause damage to cells and tissues (Kamlesh et al. 2007). Compound 1 (methylinositol) is a well known antioxidant product (Jiang et al. 2013). Though with significantly (p < 0.05) lower radical scavenging activity compared to L-ascorbic acid, the presence of methylinositol in the leaves of P. pinnata could trigger its recommendation as a natural alternative to the use of L-ascorbic acid as an antioxidant.
Table 3

DPPH radical scavenging activities of the extracts and compounds from P. pinnata leave s and stems

Test substance

RSa50 (μg/ml)

Extracts

Extracta

116.74 ± 4.20cd

Extractb

99.61 ± 4.69c

Compounds

1

19.27 ± 4.43b

2

nd

3

nd

4

247.30 ± 6.22f

5

4763.60 ± 38.26h

6

865.88 ± 26.84g

7

147.23 ± 5.71e

Reference

Vitamin C

5.31 ± 1.09a

Extracta, leaf extract; Extractb, stem extract. Along each column, values with the same letter superscripts are not significantly different. Waller Dunkan (p < 0.05).; nd: not determined (RSa50 > 5000 μg/ml).

The results show that a phytmedicine may possess numerous biological properties and this is the case of P. pinnata with both antityphoid and radical scavenging activities. The antibacterial activity of P. pinnata may be enhanced by its antioxidant property since Compound 1 with a relatively good antisalmonellal activity equally displayed outstanding radical scavenging activity.

Conclusion

The present findings support the ethno-pharmacological exploitation of P. pinnata in the treatment of typhoid fever and hold great perspective in the development of alternative antityphoid and antioxidant phytomedicine using Compounds 5, (3β)-3-O-(2′-Acetamido-2′-deoxy-β-D-glucopyranosyl) oleanolic acid, and 1, methylinositol, respectively as markers.

Declarations

Acknowledgement

This research was supported by the Academy of Science for developing countries (TWAS) in collaboration with the Chinese Academy of Sciences (CAS). 2012 TWAS-CAS Postgraduate scholarship award FR number: 3240267247.

Authors’ Affiliations

(1)
Laboratory of Microbiology and Antimicrobial Substances, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon
(2)
Laboratory of Animal Physiology and Health, FASA, University of Dschang, P.O. Box 222, Dschang, Cameroon
(3)
Laboratory of Phytobiochemistry and Medicinal Plants Study, Faculty of Science, University of Yaoundé 1, P.O. Box 812, Yaoundé, Cameroon

References

  1. Abdel-Kader M, Hoch J, Berger MJ, Evans R, Miller SJ, Wisse HJ, Mamber WS, Dalton MJ, Kingston GID: Two Bioactive Saponins from Albizia subdimidiata from the Suriname Rainforest. J Nat Prods 2001, 64: 536-539. 10.1021/np000295uView ArticleGoogle Scholar
  2. Abhishek SS, Alok SW, Archana RJ: Immunomodulatory activity of methanolic extract of Murraya Koenigii (L) Spreng leaves. Indian J Exp Biol 2008, 46(7):505-509.Google Scholar
  3. Alam MS, Chopra N, Ali M, Niwa M: Oleanen and stigmasterol derivatives from Ambroma augusta . Phytochemistry 1996, 41(4):1197-1200. 10.1016/0031-9422(95)00774-1View ArticleGoogle Scholar
  4. Ammah A, Akenji TN, Ndip R, Deas JE: An update on concurrent malaria and typhoid fever in Cameroon. T roy Soc Trop Med H 1999, 93(1):127-129.View ArticleGoogle Scholar
  5. Annan K, Gbedema SY, Adu F: Antibacterial and radical scavenging activity of fatty acids from Paullinia pinnata L. Pharmaco Mag 2009, 5(19):119-123.Google Scholar
  6. Arafa IH, Sonia P, Giuseppina A, Stefania M, Cosimo P, Wieslaw O: Antiproliferative hopane and oleanane glycosides from the roots of Glinus lotoides . Planta Med 2005, 71: 554-560. 10.1055/s-2005-864158View ArticleGoogle Scholar
  7. Benson JP, Cales B: Animal anatomy and physiology. Dubuque. In Laboratory text book. Wm.C. Brown Communication, Iowa-USA; 1992:325-341.Google Scholar
  8. Bowden K: Isolation from Paullinia pinnata of material with action on the isolated frog heart. Brit J Pharmacol 1962, 18: 173-174.Google Scholar
  9. Chabra SC, Makuna RLA, Mshiu EN: Plants used in traditional medicine in Eastern Tanzania. J Ethnopharmacol 1991, 33(1–2):143-157.View ArticleGoogle Scholar
  10. De Almeida MV, Couri MRC, De Assis JV, Anconi CPA, Dos Santos HF, De Almeida WB: 1H NMR analysis of O-methyl-inositol isomers: a joint experimental and theoretical study. Magn Reson Chem 2012, 50: 608-614. 10.1002/mrc.3848View ArticleGoogle Scholar
  11. De Diego-Otero Y, Romero-Zerbo Y, El Bekay R, Decara J, Sanchez L, Rodriguez-de Fonseca F, Del Arco-Herrera I: Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency. Neuropsychopharmacol 2009, 34(4):1011-1026. 10.1038/npp.2008.152View ArticleGoogle Scholar
  12. Dongo E, Hussain H, Miemanang SR, Tazoo D, Schulz B, Krohn K: Chemical Constituents of Klainedoxa gabonenses and Paullinia pinnata . Record Nat Prods 2009, 3(3):165-169.Google Scholar
  13. Ehab AA, Ngeh JT, John CJ, Ikhlas AK: Two New Flavone Glycosides from Paullinia pinnata . J Nat Prods 1999, 62: 1179-1181. 10.1021/np990063zView ArticleGoogle Scholar
  14. El-Ghorab A, Mahgoub M, Bekheta M: Effect of some bioregulators on the chemical composition of essential oil and its antioxidant activity of Egyptian carnation ( Dianthus caryophyllus ). J Essent Oil- Bearing Plants 2006, 9: 214-222.View ArticleGoogle Scholar
  15. Everest P, Wain J, Roberts M, Rook G, Dougan G: The molecular mechanisms of severe typhoid fever. Trends Microbiol 2001, 9(7):316-320. 10.1016/S0966-842X(01)02067-4View ArticleGoogle Scholar
  16. Gatsing D, Mbah JA, Garba IH, Tane P, Djemgou PNji-Nkah BF: An antisalmonellal agent from the leaves of Glossocalyx brevipes Benth (Monimiaceae). Pak J Biol Sci 2006, 9(1):84-87.View ArticleGoogle Scholar
  17. Gatsing D, Djemgou PC, Garba IH, Aliyu R, Tchuendem MH, Tane P, Ngadjui BT, Seguin E, Adoga GI: Dihydronaphtalenone and chromone from Cassia petersiana Bolle, and the antisalmonellal activity of its crude extract. Res J Phytochem 2007, 1(1):40-45.View ArticleGoogle Scholar
  18. Gatsing D, Nkeng PEA, Kuiate JR, Adoga GI: Antisalmonellal properties and acute toxicity study of Erythrina klainei Pierre (Fabaceae) bark extracts and fractions. Res Rev Biosci 2007, 1(1):35-41.Google Scholar
  19. Gupta R, Sharma K, Dobhal MP, Sharma MC, Gupta RS: Antidiabetic and antioxidant potential of β-sitosterol instreptozotocin-induced experimental hyperglycemia. J Diabetes 2011, 3: 29-37. 10.1111/j.1753-0407.2010.00107.xView ArticleGoogle Scholar
  20. Jiang WD, Kuang SY, Liu Y, Jiang J, Hu K, Li SH, Tang L: Effect of myo -inositol of proliferation, differentiation, oxidative status and antioxidant capacity of carp enterocytes of primary culture. Aquacult Nutri 2013, 19: 45-53. 10.1111/j.1365-2095.2011.00934.xView ArticleGoogle Scholar
  21. Kallio H, Lassila M, Jarvenpaa E, Haraldsson GG, Jonsdottir S, Yanga B: Inositols and methylinositols in sea buckthorn ( Hippopha? rhamnoides ) berries. J Chromatogr B 2009, 877: 1426-1432. 10.1016/j.jchromb.2009.03.027View ArticleGoogle Scholar
  22. Kamgang R, Ervice VPK, Marie CF, Veronique PNB: Activities of aqueous extracts of Mallotus oppositifolium on Shigella dysenteriae A1- induced diarrhoea in rats. Clin Exp Pharmacol Physiol 2006, 33(1–2):89-94.View ArticleGoogle Scholar
  23. Kamlesh D, Yogesh S, Ajit P: Evaluation of in vitro antioxidant activity of Sida rhombifolia (L.) Ssp. retusa (L.). J Med Food 2007, 10(4):683-688. 10.1089/jmf.2006.129View ArticleGoogle Scholar
  24. Kerharo J, Adam JG: La Pharmacopee Senegalaise Tradionelle: plantes. Medicinales et toxiques, vol 1. Vigot, Paris; 1974:101.Google Scholar
  25. Klass J, Tinto WF, McLean S, Reynolds WF: Friedelane triterpenoids from Peritassa compta: Complete 1H-NMR and 13C-NMR assignments by 2D NMR spectroscopy. J Nat Prods 1992, 55: 1626-1630. 10.1021/np50089a010View ArticleGoogle Scholar
  26. Lalitagauri D, Paul R, Thomas R, Helio S, Ronald N: Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates. Diag Microbiol Infect Dis 2004, 50(1):73-75. 10.1016/j.diagmicrobio.2004.04.011View ArticleGoogle Scholar
  27. Lee JH, Lee JY, Park JH, Jung HS, Kim JS, Kang SS, Kim YS, Han Y: Immunoregulatory activity by daucosterol, a beta-sitosterol glycoside, induces protective Th1 immune response against disseminated Candidiasis in mice. Vaccine 2007, 25(19):3834-3840. 10.1016/j.vaccine.2007.01.108View ArticleGoogle Scholar
  28. Magadula JJ, Tewtrakul S, Gatto J, Richomme P: In vitro antioxidant and anti-HIV-1 protease (PR) activities of two Clusiaceae plants endemic to Tanzania. Int J Biol Chem Sci 2011, 5(3):1096-1104.Google Scholar
  29. Mahato SB, Kundu AP: 13C NMR Spectra of pentacyclic triterpenoids - a compilation and some salient features. Phytochem 1994, 37: 1517-1575. 10.1016/S0031-9422(00)89569-2View ArticleGoogle Scholar
  30. Mativandlela SPN, Lall N, Meyer JJM: Antibacterial, antifungal and antitubercular activity of Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root extracts. South Afrn J Botany 2006, 72(2):232-237. 10.1016/j.sajb.2005.08.002View ArticleGoogle Scholar
  31. Matook SM, Fumio H: Evaluation of the antimicrobial activity of extract from Buntan ( Citrus grandis Osbeck) fruit peel. Pak J Biol Sci 2005, 8(8):1090-1095.View ArticleGoogle Scholar
  32. Nauciel C, Vildé JL: Bactériologie Médicale. 2nd edition. Elsevier Masson, France; 2005:257.Google Scholar
  33. Newton SM, Lau C, Gurcha SS, Besra GS, Wright CW: The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis . J Ethnopharmacol 2002, 79(1):57-67. 10.1016/S0378-8741(01)00350-6View ArticleGoogle Scholar
  34. Ngassapa O, Beecher WWC, Pezzuto MJ, Farnsworth RN: Isolation of echinocystic acid-3-o-sulfate, a new triterpene, from Tetrapleura tetraptera, and evaluation of the mutagenic potential of molluscicidal extracts and isolates. J Nat Prods 1993, 56(11):1872-1877. 10.1021/np50101a002View ArticleGoogle Scholar
  35. Rastaldo R, Pagliaro P, Cappello S, Penna C, Mancardi D, Westerhof N, Losano G: Nitric oxide and cardiac function. Life Sci 2007, 81(10):779-793. 10.1016/j.lfs.2007.07.019View ArticleGoogle Scholar
  36. Seifried HE, Anderson DE, Fisher EI, Milner JA: A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 2007, 18(9):567-579. 10.1016/j.jnutbio.2006.10.007View ArticleGoogle Scholar
  37. Tamokou JD, Tala MF, Wabo KH, Kuiate JR, Tane P: Antimicrobial activities of methanol extract and compounds from stem bark of Vismia rubescens . J Ethnopharmacol 2009, 124(3):571-575. 10.1016/j.jep.2009.04.062View ArticleGoogle Scholar
  38. Tereshuck ML, Riera MVQ, Castro GR, Abdala LR: Antimicrobial Activity of Flavonoid from Leaves of Tagetes Minuta . J Ethnopharmacol 1997, 56(3):227-232. 10.1016/S0378-8741(97)00038-XView ArticleGoogle Scholar
  39. Theml H: Atlas de poche d’hématologie. Flammarion Médecine-Science, pour la tradition Française. ISBN, Paris; 2000:2-21.Google Scholar
  40. Weinberg ED: Survival advantage of the hemochromatosis C282Y mutation. Perspectives Biol Med 2008, 51(1):98-102.View ArticleGoogle Scholar
  41. WHO: Research Guidelines for Evaluating the safety and efficacy of herbal medicines. Manila. Meeting of the working group on the safety and efficacy of herbal medicine/World Health Organization, Geneva; 1992.Google Scholar
  42. WHO: The World Health Report 1996- Fighting disease, fostering development. World Health Organization, Geneva; 1996.Google Scholar
  43. Yassa N, Razavi BH, Hadjiakhoondi A: Free radical scavenging and lipid peroxidation activity of the shahani black grape. Pak J Biol Sci 2008, 11(21):2513-2516. 10.3923/pjbs.2008.2513.2516View ArticleGoogle Scholar
  44. Zafer U, Nazlı B, ElÇin T, Ömer K, İhsan Y, Süheyla K: Flavonoid glycosides and methylinositol from Ebenus haussknechtii . Nat Prod Res 2007, 20(11):999-1007.Google Scholar

Copyright

© Lunga et al.; licensee Springer. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

Advertisement